cb-010,fludarabine,cyclophosphamide
Caribou Biosciences
['car-t', 'ribo']
$crbu caribou biosciences reports positive additional data from cb-010 allogeneic car-t cell therapy phase 1 antler trial at the european hematology association (eha) 2022 hybrid congress 100% cr rate, with 40% cr rate (2 of 5 patients) at 6 months 
The Lady Who Can Tell Time. Currently Taking Care of My Chicken, I am that "fuckin Michelle on Twitter"